1515.HK WACC - Weighted Average Cost of Capital

The WACC of China Resources Medical Holdings Company Ltd (1515.HK) is 7.6%.

The Cost of Equity of China Resources Medical Holdings Company Ltd (1515.HK) is 9.05%.

The Cost of Debt of China Resources Medical Holdings Company Ltd (1515.HK) is 6.10%.

	Range	Selected
Cost of equity	7.00% - 11.10%	9.05%
Tax rate	23.00% - 27.40%	25.20%
Cost of debt	4.00% - 8.20%	6.10%
WACC	5.8% - 9.5%	7.6%

WACC

1515.HK WACC calculation

Category	Low	High

Long-term bond rate	2.9%	3.4%
Equity market risk premium	6.0%	7.0%
Adjusted beta	0.7	1.03

Additional risk adjustments	0.0%	0.5%
Cost of equity	7.00%	11.10%

Tax rate	23.00%	27.40%
Debt/Equity ratio	0.46	0.46
Cost of debt	4.00%	8.20%

After-tax WACC	5.8%	9.5%


Selected WACC	7.6%

1515.HK's CAPM model and how its cost of Equity is calculated

The Cost of Equity reflects the return a company needs to deliver to shareholders to justify the risk of investing in its shares. It’s computed using the Capital Asset Pricing Model (CAPM), which blends the risk-free rate, the stock’s beta, and the market risk premium.

This method evaluates the stock’s risk compared to a safe investment and the market’s overall volatility.

Here’s how we figure out the cost of equity for 1515.HK:

cost_of_equity (9.05%) = risk_free_rate (3.15%) + equity_risk_premium (6.50%) * adjusted_beta (0.7) + risk_adjustments (0.25%)

We include the risk adjustments, which range from 0% to 1%, to keep our WACC conservatives, especially for companies traded in developing markets.